Company MannKind Corporation Nasdaq
Equities
US56400P2011
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Therapeutic Products and Devices
100.0
%
| 100 | 100.0 % | 199 | 100.0 % | +99.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 100 | 100.0 % | 199 | 100.0 % | +99.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 47 | 14/16/14 |
Sanjay Singh
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/22/01 |
Kevin Kaiserman
CTO | Chief Tech/Sci/R&D Officer | - | 31/20/31 |
Joseph Kocinsky
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/03/01 |
Burkhard Blank
CTO | Chief Tech/Sci/R&D Officer | 69 | 24/23/24 |
Lauren Sabella
COO | Chief Operating Officer | 63 | 27/23/27 |
Investor Relations Contact | 63 | 01/03/01 | |
Steven Binder
PRN | Corporate Officer/Principal | 61 | 17/17/17 |
Karen Jaffe
LAW | General Counsel | - | 01/20/01 |
David Thomson
LAW | General Counsel | 57 | 01/02/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 27/18/27 | |
Anthony Hooper
BRD | Director/Board Member | 69 | 01/20/01 |
Ronald Consiglio
BRD | Director/Board Member | 80 | 01/03/01 |
Kent Kresa
BRD | Director/Board Member | 86 | 01/04/01 |
Michael Friedman
BRD | Director/Board Member | 80 | 01/03/01 |
Jennifer Grancio
BRD | Director/Board Member | 52 | 23/20/23 |
Sabrina Kay
BRD | Director/Board Member | 61 | 01/20/01 |
James Shannon
CHM | Chairman | 67 | 21/15/21 |
Michael Castagna
CEO | Chief Executive Officer | 47 | 14/16/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 270,679,296 | 266,543,127 ( 98.47 %) | 0 | 98.47 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- MNKD Stock
- Stock
- Company MannKind Corporation